3 news items
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
ALDX
25 Apr 24
will be accessible from the "Investors & Media" section of the Aldeyra website
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
ALDX
18 Apr 24
and slide presentation will be accessible from the "Investors & Media" section of the Aldeyra website
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
ALDX
LGND
MRK
27 Feb 24
providing the company with access to up to $400 million from funds managed by Oxford Finance LLC and Hercules Capital, Inc. The debt facility provides non
- Prev
- 1
- Next